Esperion Therapeutics | ESPR - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 58.94B 4.03B 2025-12
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
Amgen USD 51.89B 1.88B 2026-03
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Cipla INR 3.82B 840.2M 2026-03
CSL USD 10.42B 273M 2025-12
Cytokinetics USD 247.21M 868.77M 2026-03
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 39.37B 1.5B 2026-03
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Geron USD 119.83M 286K 2026-03
Grifols EUR 9.95B 722.93M 2025-12
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Merck USD 46.67B 77M 2026-03
Minerva Neurosciences USD 0 86.58M 2024-09
Moderna USD 603M 7M 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Sanofi EUR 13.84B 1.88B 2026-03
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12